Literature DB >> 26183747

A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.

Tetsuji Yamashita1, Natsuko Morotomi, Tetsuro Sohda, Hisao Hayashi, Naohiko Yoshida, Keiko Ochi, Izumi Ohkura, Mika Karita, Hiroko Fujiwara, Haruhiko Yamashita, Ai Hattori, Yasuaki Tatsumi.   

Abstract

Reticuloendothelial iron overload is associated with secondary hemochromatosis including repeated transfusions and iron over-supplementation. Ferroportin disease B is a severe subtype of hereditary iron overload syndrome with an activated reticuloendothelial system. The iron exporter ferroportin may be insensitive to hepcidin 25 in this subtype. However, the interactions between the hepcidin-ferroportin system and modifiers of reticuloendothelial iron overload have not yet been elucidated. We describe two patients with iron overload conditions that were compatible with ferroportin disease B, but their genetic backgrounds and habitual states differed. Both patients had diabetes, periportal fibrosis with severe iron deposits in their hepatocytes and Kupffer cells, and adequate levels of circulating hepcidin 25. However, the first patient was heterozygous for a mutation in the FP gene and free from the acquired factors of iron overload, while the second patient was a heavy drinker with a heterozygous mutation in the TFR2 gene and no mutations in the FP gene. The first patient was the second reported case of ferroportin disease B in Japan. Our study on these 2 patients suggests that liver fibrosis associated with compound iron overload of reticuloendothelial cells and hepatocytes may occur via multi-etiological backgrounds.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26183747     DOI: 10.1007/s12328-014-0487-1

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  15 in total

1.  Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.

Authors:  Luís Costa-Matos; Paulo Batista; Nuno Monteiro; Maria Simões; Conceição Egas; Jorge Pereira; Helena Pinho; Natália Santos; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Alfredo Rodrigues; Armando Carvalho
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 2.566

2.  A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.

Authors:  Chizu Koyama; Shinya Wakusawa; Hisao Hayashi; Toshio Ueno; Rie Suzuki; Motoyoshi Yano; Hiroshi Saito; Toru Okazaki
Journal:  Intern Med       Date:  2005-09       Impact factor: 1.271

3.  Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

Authors:  Hal Drakesmith; Lisa M Schimanski; Emma Ormerod; Alison T Merryweather-Clarke; Vip Viprakasit; Jon P Edwards; Emma Sweetland; Judy M Bastin; Diana Cowley; Yingyong Chinthammitr; Kathryn J H Robson; Alain R M Townsend
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

Review 4.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

Review 5.  Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin.

Authors:  L M Fletcher; J W Halliday; L W Powell
Journal:  J Gastroenterol Hepatol       Date:  1999-03       Impact factor: 4.029

Review 6.  Genetic background of primary iron overload syndromes in Japan.

Authors:  Hisao Hayashi; Shinya Wakusawa; Satoshi Motonishi; Ken-ichi Miyamoto; Hidetoshi Okada; Yasutaka Inagaki; Takaaki Ikeda
Journal:  Intern Med       Date:  2006-11-15       Impact factor: 1.271

7.  Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.

Authors:  Weidong Liu; Souji Shimomura; Hiroyasu Imanishi; Yuna Iwamoto; Naoto Ikeda; Masaki Saito; Masao Ohno; Naoki Hara; Tetsuo Yamamoto; Hideji Nakamura; Toshikazu Hada
Journal:  Intern Med       Date:  2005-04       Impact factor: 1.271

8.  A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.

Authors:  Emilie Létocart; Gérald Le Gac; Silvia Majore; Chandran Ka; Francesca C Radio; Isabelle Gourlaouen; Carmelilia De Bernardo; Claude Férec; Paola Grammatico
Journal:  Br J Haematol       Date:  2009-08-25       Impact factor: 6.998

Review 9.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Clinicopathological study of Japanese patients with genetic iron overload syndromes.

Authors:  Ai Hattori; Hiroaki Miyajima; Naohisa Tomosugi; Yasuaki Tatsumi; Hisao Hayashi; Shinya Wakusawa
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

View more
  4 in total

1.  Inclusion bodies of aggregated hemosiderins in liver macrophages.

Authors:  Hisao Hayashi; Yasuaki Tatsumi; Shinya Wakusawa; Ryota Shigemasa; Ryoji Koide; Ken-Ichi Tsuchida; Natsuko Morotomi; Tetsuji Yamashita; Kotaro Kumagai; Yukiya Ono; Kazuhiko Hayashi; Masatoshi Ishigami; Hidemi Goto; Ayako Kato; Koichi Kato
Journal:  Med Mol Morphol       Date:  2017-06-19       Impact factor: 2.309

Review 2.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

3.  A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.

Authors:  Hisao Hayashi; Motoyoshi Yano; Naohito Urawa; Akane Mizutani; Shima Hamaoka; Jun Araki; Yuji Kojima; Yutaka Naito; Ayako Kato; Yasuaki Tatsumi; Koichi Kato
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

Review 4.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.